RadNet, Inc. Common Stock (RDNT) is a publicly traded Healthcare sector company. As of May 19, 2026, RDNT trades at $53.56 with a market cap of $4.12B and a P/E ratio of -300.31. RDNT moved -1.48% today. Year to date, RDNT is -23.65%; over the trailing twelve months it is -11.40%. Its 52-week range spans $45.00 to $93.65. Analyst consensus is strong buy with an average price target of $85.00. Rallies surfaces RDNT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies organizes RDNT SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
| Metric | Value |
|---|---|
| Price | $53.56 |
| Market Cap | $4.12B |
| P/E Ratio | -300.31 |
| EPS | $-0.18 |
| Dividend Yield | 0.00% |
| 52-Week High | $93.65 |
| 52-Week Low | $45.00 |
| Volume | 133.27K |
| Avg Volume | 0 |
| Revenue (TTM) | $2.14B |
| Net Income | $22.05M |
| Gross Margin | 0.00% |
5 analysts cover RDNT: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $85.00.